Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015

Malignant neoplasms are the leading cause of death in Korea. We aimed to examine if metformin use in cancer survivors reduces all-cause mortality. This study was retrospectively designed based on data from the Korean National Health Insurance Service-National Health Screening Cohort (HEALS) between...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Joungyoun, Bae, Yoon-Jong, Lee, Jae-woo, Kim, Ye-seul, Kim, Yonghwan, You, Hyo-Sun, Kim, Hyeong-Seop, Choi, Eun-A, Han, Ye-Eun, Kang, Hee-Taik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982185/
https://www.ncbi.nlm.nih.gov/pubmed/33725979
http://dx.doi.org/10.1097/MD.0000000000025045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982185/
https://www.ncbi.nlm.nih.gov/pubmed/33725979
http://dx.doi.org/10.1097/MD.0000000000025045

Ejemplares similares